95 related articles for article (PubMed ID: 9797872)
1. Characterization of an MDR1 retroviral bicistronic vector for correction of X-linked severe combined immunodeficiency.
Kleiman SE; Pastan I; Puck JM; Gottesman MM
Gene Ther; 1998 May; 5(5):671-6. PubMed ID: 9797872
[TBL] [Abstract][Full Text] [Related]
2. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.
Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM
Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919
[TBL] [Abstract][Full Text] [Related]
3. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.
Sugimoto Y; Tsukahara S; Sato S; Suzuki M; Nunoi H; Malech HL; Gottesman MM; Tsuruo T
J Gene Med; 2003 May; 5(5):366-76. PubMed ID: 12731085
[TBL] [Abstract][Full Text] [Related]
4. Retroviral coexpression of two different types of drug resistance genes to protect normal cells from combination chemotherapy.
Suzuki M; Sugimoto Y; Tsukahara S; Okochi E; Gottesman MM; Tsuruo T
Clin Cancer Res; 1997 Jun; 3(6):947-54. PubMed ID: 9815770
[TBL] [Abstract][Full Text] [Related]
5. Construction and characterization of bicistronic retroviral vectors encoding the multidrug transporter and beta-galactosidase or green fluorescent protein.
Aran JM; Gottesman MM; Pastan I
Cancer Gene Ther; 1998; 5(4):195-206. PubMed ID: 9694071
[TBL] [Abstract][Full Text] [Related]
6. [Efficient expression of multidrug resistance gene mdr1 in retroviral vector under control of an internal ribosome entry site].
Fu J; Chen Z; Wang W
Zhonghua Xue Ye Xue Za Zhi; 1998 Dec; 19(12):619-22. PubMed ID: 11263327
[TBL] [Abstract][Full Text] [Related]
7. Lymphoid development and function in X-linked severe combined immunodeficiency mice after stem cell gene therapy.
Otsu M; Anderson SM; Bodine DM; Puck JM; O'Shea JJ; Candotti F
Mol Ther; 2000 Feb; 1(2):145-53. PubMed ID: 10933924
[TBL] [Abstract][Full Text] [Related]
8. Genetic modification of hematopoietic progenitor cells for combined resistance to 4-hydroperoxycyclophosphamide, vincristine, and daunorubicin.
Wang JS; Fang Q; Sun DJ; Chen J; Zhou XL; Lin GW; Lu HZ; Fei J
Acta Pharmacol Sin; 2001 Oct; 22(10):949-55. PubMed ID: 11749781
[TBL] [Abstract][Full Text] [Related]
9. A bicistronic retroviral vector to introduce drug resistance genes into human umbilical cord blood CD34+ cells to improve combination chemotherapy tolerance.
Wang J; Chen Z; Xia X; Lu D; Xue J; Ruan C
Chin Med J (Engl); 2001 Jan; 114(1):25-9. PubMed ID: 11779430
[TBL] [Abstract][Full Text] [Related]
10. Retroviral MDR1 gene transfer into marrow-engrafting human peripheral blood progenitor cells results in preferential transgene expression in the immature myeloid compartment rather than in mature myeloid progeny in vivo.
Buss EC; Laufs S; Naundorf S; Kuehlcke K; Nagy KZ; Zeller WJ; Fruehauf S
Cytotherapy; 2006; 8(6):562-9. PubMed ID: 17148033
[TBL] [Abstract][Full Text] [Related]
11. Chemoprotection effect of multidrug resistance 1 (MDR1) gene transfer to hematopoietic progenitor cells and engrafted in mice with cancer allows intensified chemotherapy.
Guo C; Jin X
Cancer Invest; 2006 Nov; 24(7):659-68. PubMed ID: 17118775
[TBL] [Abstract][Full Text] [Related]
12. Chemoprotection effect of retroviral vector encoding multidrug resistance 1 gene to allow intensified chemotherapy in vivo.
Guo CB; Li YC; Jin XQ
Cancer Chemother Pharmacol; 2006 Jul; 58(1):40-9. PubMed ID: 16284790
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes.
Guan J; Ma L; Wei L
Chin Med J (Engl); 2001 Feb; 114(2):147-51. PubMed ID: 11780195
[TBL] [Abstract][Full Text] [Related]
14. [Construction and application of retroviral vector system useful for high-efficiency transfection into human T cells].
Zhang RP; Yun L; Peng L; Lu B; Zhou Q; Wang H; Guo YJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):420-2, 426. PubMed ID: 16805997
[TBL] [Abstract][Full Text] [Related]
15. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors.
Gan HZ; Zhang GZ; Zhao JS; Zhang FC; Bu LS; Yang SJ; Piao SL; Du ZW; Gao S; Zheng DM
Chin Med J (Engl); 2005 Jun; 118(11):893-902. PubMed ID: 15978189
[TBL] [Abstract][Full Text] [Related]
16. Bicistronic retroviral vectors for combining myeloprotection with cell-surface marking.
Hildinger M; Schilz A; Eckert HG; Bohn W; Fehse B; Zander A; Ostertag W; Baum C
Gene Ther; 1999 Jul; 6(7):1222-30. PubMed ID: 10455430
[TBL] [Abstract][Full Text] [Related]
17. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
[TBL] [Abstract][Full Text] [Related]
18. In vivo RNA interference-mediated ablation of MDR1 P-glycoprotein.
Pichler A; Zelcer N; Prior JL; Kuil AJ; Piwnica-Worms D
Clin Cancer Res; 2005 Jun; 11(12):4487-94. PubMed ID: 15958634
[TBL] [Abstract][Full Text] [Related]
19. Impact of splice-site mutations of the human MDR1 cDNA on its stability and expression following retroviral gene transfer.
Cmejlova J; Hildinger M; Cmejla R; Fuchs O; Kalabova D; Baum C; Jelinek J
Gene Ther; 2003 Jun; 10(12):1061-5. PubMed ID: 12776165
[TBL] [Abstract][Full Text] [Related]
20. Retroviral vector for gene therapy of X-linked severe combined immunodeficiency syndrome.
Qazilbash MH; Walsh CE; Russell SM; Noguchi M; Mann MM; Leonard WJ; Liu JM
J Hematother; 1995 Apr; 4(2):91-8. PubMed ID: 7633846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
